Perfusion Systems Market Scope
Perfusion Systems enables the passage of blood or other fluid through the circulatory channels in an organ or tissue. These systems are widely used in organ transplantation procedures. These systems are used to bypass cardiopulmonary systems in order to treat patients with cardiac and respiratory diseases surgically. As per the sources, in 2019, a total of 39,718 transplants were performed in the United States. Although 90% of United States adults support organ donation only 60% of people actually sign up as donors. As of September 2020, over 109,000 men, women, and children were on the transplant waiting list. This has resulted in an increased mortality rate hence is surging the demand for perfusion systems to improve the viability of the organ.
According to AMA, the Global Perfusion Systems market is expected to see growth rate of 4.91%The global perfusion systems market is largely competitive and consists of several vendors who compete based on factors such as features, product quality, technology, size, and product pricing. The intense competition, changing consumer spending patterns, demographic trends, and frequent changes in consumer preferences pose significant risk factors for the growth of manufacturers in the market. Research Analyst at AMA estimates that United States Players will contribute to the maximum growth of Global Perfusion Systems market throughout the predicted period.
Getinge AB (Sweden), Medtronic plc (Ireland), LivaNova PLC (United Kingdom), Terumo Corporation (Japan), XENIOS AG (Germany), Lifeline Scientific, Inc. (United States), XVIVO Perfusion AB (Sweden), Repligen Corporation (United States), Spectrum Laboratories, Inc. (United States), Merck KGaA (Germany), Harvard Bioscience, Inc. (United States) and ALA Scientific Instruments, Inc. (United States) are some of the key players that are part of study coverage. Additionally, the Players which are also part of the research are Organ Assist B.V. (Netherlands), Organ Transport Systems Inc. (United States), Nipro Corporation (Japan), TransMedics, Inc. (United States), OrganOx Limited (United Kingdom), Bridge to Life Ltd (United States) and Philips (Netherlands).
Segmentation Overview
The study have segmented the market of Global Perfusion Systems market by Type (Bioreactor Perfusion Systems, Microfluidic Perfusion Systems, Gravity Or Pressure-Driven Perfusion Systems and Small-Mammal Organ Perfusion Systems), by Application (Cardiovascular Diseases and Respiratory Diseases) and Region with country level break-up.
On the basis of geography, the market of Perfusion Systems has been segmented into South America (Brazil, Argentina, Rest of South America), Asia Pacific (China, Japan, India, South Korea, Taiwan, Australia, Rest of Asia-Pacific), Europe (Germany, France, Italy, United Kingdom, Netherlands, Rest of Europe), MEA (Middle East, Africa), North America (United States, Canada, Mexico).
Influencing Trend:
Technological Advancements In Medical Devices
Market Growth Drivers:
Increasing Number Of Organ Transplantations Due To Incidence Of Multiple Organ Failure and Growing Prevalence Of Cardiovascular And Respiratory Diseases
Challenges:
Organ Supply-Demand Gap
Restraints:
High Cost Of Organ Transplantation and Ethical Concerns And High Cost Of Cell-Based Research
Opportunities:
Rising Pharmaceutical Research In Emerging Markets and Increasing Initiatives To Promote Organ Donation
Market Leaders and their Expansionary Development Strategies
In August 2023 TransMedics Group, Inc. a medical technology company that is transforming organ transplant therapy for patients with end-stage lung, heart, and liver failure, announced today that is has acquired from Bridge to Life Ltd.assets and intellectual property related to the Ex-Vivo Organ Support System and LifeCradle Heart Preservation Transport System technologies.
In January 2024,Inspira Technologies OXY B.H.N Ltd. (Nasdaq: IINN) (Nasdaq: IINNW) (the "Company" or "Inspira"), a pioneer in life support technology with a vision to supersede traditional mechanical ventilators, today announced its plan to launch a single-use disposable blood oxygenation kit (the "Kit"), currently in development, for its INSPIRA ART medical device series.
Key Target Audience
New Entrants/Investors, Analysts and Strategic Business Planners, Perfusion Systems Manufacturer, Raw Material Suppliers, Dealers, Suppliers, Traders, and Distributors, Venture Capitalists and Private Equity Firms, Government Regulatory and Research Organizations and End-Use Industry
About Approach
The research aims to propose a patent-based approach in searching for potential technology partners as a supporting tool for enabling open innovation. The study also proposes a systematic searching process of technology partners as a
preliminary step to select the emerging and key players that are involved in implementing market estimations. While patent analysis is employed to overcome the aforementioned data- and process-related limitations, as expenses occurred in that technology allows us to estimate the market size by evolving segments as target market from the total available market.